Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 65 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionBuchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
2003Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse modelStroeher, U.; Paton, A.; Ogunniyi, A.; Paton, J.
2004The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challengeKwon, H.; Ogunniyi, A.; Choi, M.; Pyo, S.; Rhee, D.; Paton, J.
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2004Effect of β₂‐glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody‐mediated pregnancy pathology in miceRobertson, S.; Roberts, C.; van Beijering, E.; Pensa, K.; Sheng, Y.; Shi, T.; Krilis, S.
2008Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoformSharma, S.; Burdon, K.; Dave, A.; Jamieson, R.; Yaron, Y.; Billson, F.; van Maldergem, L.; Lorenz, B.; Gecz, J.; Craig, J.
2001Collocation of androgen receptor gene mutations in prostate cancerBuchanan, G.; Greenberg, N.; Scher, H.; Harris, J.; Marshall, V.; Tilley, W.
2003Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulenceMorona, R.; Daniels, C.; Van Den Bosch, L.
2004Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonistPilkington, K.; Clark-Lewis, I.; McColl, S.
2001The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptorKlingler-Hoffmann, M.; Fodero-Tavoletti, M.; Mishima, K.; Narita, Y.; Cavenee, W.; Furnari, F.; Huang, H.; Tiganis, T.